On this page

Bat

Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Bat

Proper name

Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)

Licence type

351(a)

BLA number

125462

Applicant

Emergent BioSolutions Canada Inc.

Center

CBER

Presentations

First licensure

—

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
>4500U	Solution	Intravenous	Single-Dose Vial	Rx	March 22, 2013

Source: Purple Book

Kind	Expires
Orphan exclusivity	March 22, 2020

Purple Book	FDA	Licence type, presentations, reference product, exclusivity